Merlin test
Commercial- Indications
- Melanoma
Company intelligence / Profile preview
SkylineDx
Rotterdam, South Holland, Netherlandsskylinedx.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SkylineDx has developed and commercialized several molecular diagnostic tests that are CE-IVD marked in Europe. The Merlin™ Assay for melanoma nodal metastasis risk is commercially available in partnership with Biocartis. The MMProfiler assay for multiple myeloma has also received CE-IVD marking. Ongoing clinical collaborations aim to validate new biomarker-driven tests across oncology and inflammatory diseases.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Diagnostic assayMolecular diagnostic test
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Biocartis (co-development/commercialization of Merlin™ Assay for melanoma metastasis risk reduction in Europe)NeraCare (co-development/licensing agreement on Immunoprint proteomic test for high-risk early-stage melanoma patients)Flanders Institute of Biotechnology/VIB (“molecular diagnostics partnership” focused on unmet needs globally using single-cell technology to map tumor microenvironments and validate immunotherapy response biomarkers)
Beyond the preview
Go deeper on SkylineDx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SkylineDx.